Therefore, ROS-induced TRPM2 channel activation has been proposed to contribute to the pathogenesis of ischemia stroke and neurodegenerative conditions such as Alzheimer’s disease (AD) and Parkinson’s diseases (PD) [25,26,27,28,29,30]. Here, TRPM2 is linked to Parkinson disease.